LEASE TERMINATION AGREEMENTLease Termination Agreement • May 23rd, 2017 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 23rd, 2017 Company Industry JurisdictionThis Lease Termination Agreement (this “Agreement”) dated as of May 19, 2017 is entered into between Cambridge 1030 Mass Ave, LLC, a Delaware limited liability company (“Landlord”), and Jounce Therapeutics, Inc. a Delaware corporation (“Tenant”).
SUBLEASE TERMINATION AGREEMENTSublease Termination Agreement • May 23rd, 2017 • Jounce Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 23rd, 2017 Company Industry JurisdictionTHIS SUBLEASE TERMINATION AGREEMENT (“Agreement”) is made and entered into as of May 19, 2017 by and between MANUS BIOSYNTHESIS, INC., a Delaware company (“Sublandlord”) and JOUNCE THERAPEUTICS, INC., a Delaware corporation (“Subtenant”). Sublandlord and Subtenant are each individually referred to herein as a “Party” and are collectively referred to as the “Parties”.